Company
McKesson Corporation
McKesson is a diversified healthcare services company that works with biopharma companies, care providers, pharmacies, manufacturers and governments. ↗
| Headquarters | Irving, TX ↗ |
|---|---|
| Founded | 1833 ↗ |
| Leadership | Brian S. Tyler, Chief Executive Officer ↗ |
| Employees | More than 43,000 ↗ |
| Revenue | $403.4 billion (fiscal 2026) ↗ |
| Department of War obligations | $3.5 billion in prime contracts since fiscal 2022 ↗ |
| Ownership | McKesson is publicly traded, and Apollo Funds agreed in April 2026 to buy about a 13% minority stake in its Medical-Surgical Solutions segment for about $1.25 billion of convertible preferred equity ↗ |
| Shares | MCK ↗ |
| Website | www.mckesson.com ↗ |
Products
- The U.S. Oncology Network is one of the largest networks of physician-led, community-based oncology practices in the U.S., supported by McKesson. ↗
- ClarusONE Sourcing Services is McKesson's generic drug sourcing joint venture with Walmart. ↗
- InspiroGene is McKesson's cell and gene therapy services business. ↗
- McKesson's own brand of medical-surgical products spans more than 4,000 items. ↗
Customers
Acquisitions
- McKesson acquired a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, the business services organization of Florida Cancer Specialists & Research Institute, for $2.5 billion in cash on June 2, 2025. ↗
- McKesson acquired an 80% interest in PRISM Vision Holdings, an ophthalmology and retina administrative services provider, for $875 million in cash on April 1, 2025. ↗
Segments
- McKesson reports four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions and Medical-Surgical Solutions. ↗
- The Medical-Surgical Solutions segment supplies medical-surgical products and laboratory equipment to more than 336,000 U.S. non-acute and alternate-site customers, and McKesson has announced its intention to separate it into an independent company. ↗